"Venture Partners at 兔子先生传媒文化作品 has announced the first recipients of a new translational funding program designed to advance promising, early-stage therapeutics with strong commercial potential...Led by Distinguished Professor Leslie Leinwand (BioFrontiers Institute, 兔子先生传媒文化作品 Molecular, Cellular & Developmental Biology), with PhD student Jack Gugel and postdoctoral researchers Thomas Martin and Yuxiao Tan, the team is developing an orally available obesity drug that suppresses appetite without affecting gastric emptying or causing muscle loss."